Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans.
Cipollone F, Fazia M, Iezzi A, Ciabattoni G, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, De Luca M, Prontera C, Chiarelli F, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: iezzi a. Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1259-65. doi: 10.1161/01.ATV.0000133192.39901.be. Epub 2004 May 20. Arterioscler Thromb Vasc Biol. 2004. Retraction in: Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):e1. doi: 10.1161/ATVBAHA.107.158881 PMID: 15155382 Retracted.
Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.
Cipollone F, Fazia M, Iezzi A, Zucchelli M, Pini B, De Cesare D, Ucchino S, Spigonardo F, Bajocchi G, Bei R, Muraro R, Artese L, Piattelli A, Chiarelli F, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: iezzi a. Circulation. 2003 Mar 25;107(11):1479-85. doi: 10.1161/01.cir.0000056530.03783.81. Circulation. 2003. PMID: 12654603 Clinical Trial.
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: iezzi a. Circulation. 2003 Sep 2;108(9):1070-7. doi: 10.1161/01.CIR.0000086014.80477.0D. Epub 2003 Aug 11. Circulation. 2003. PMID: 12912808
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, de Cesare D, Ucchino S, Spigonardo F, De Luca M, Muraro R, Bei R, Bucci M, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: iezzi a. Circulation. 2004 Mar 30;109(12):1482-8. doi: 10.1161/01.CIR.0000121735.52471.AC. Epub 2004 Mar 22. Circulation. 2004. PMID: 15037537 Clinical Trial.
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.
Cipollone F, Toniato E, Martinotti S, Fazia M, Iezzi A, Cuccurullo C, Pini B, Ursi S, Vitullo G, Averna M, Arca M, Montali A, Campagna F, Ucchino S, Spigonardo F, Taddei S, Virdis A, Ciabattoni G, Notarbartolo A, Cuccurullo F, Mezzetti A; Identification of New Elements of Plaque Stability (INES) Study Group. Cipollone F, et al. Among authors: iezzi a. JAMA. 2004 May 12;291(18):2221-8. doi: 10.1001/jama.291.18.2221. JAMA. 2004. PMID: 15138244
Association between 5-lipoxygenase expression and plaque instability in humans.
Cipollone F, Mezzetti A, Fazia ML, Cuccurullo C, Iezzi A, Ucchino S, Spigonardo F, Bucci M, Cuccurullo F, Prescott SM, Stafforini DM. Cipollone F, et al. Among authors: iezzi a. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1665-70. doi: 10.1161/01.ATV.0000172632.96987.2d. Epub 2005 Jun 2. Arterioscler Thromb Vasc Biol. 2005. PMID: 15933245
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
Cipollone F, Fazia ML, Iezzi A, Cuccurullo C, De Cesare D, Ucchino S, Spigonardo F, Marchetti A, Buttitta F, Paloscia L, Mascellanti M, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: iezzi a. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1925-31. doi: 10.1161/01.ATV.0000177814.41505.41. Epub 2005 Jul 14. Arterioscler Thromb Vasc Biol. 2005. PMID: 16020747
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
Cuccurullo C, Iezzi A, Fazia ML, De Cesare D, Di Francesco A, Muraro R, Bei R, Ucchino S, Spigonardo F, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A, Cipollone F. Cuccurullo C, et al. Among authors: iezzi a. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23. doi: 10.1161/01.ATV.0000249630.02085.12. Epub 2006 Oct 12. Arterioscler Thromb Vasc Biol. 2006. PMID: 17038636 Clinical Trial.
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.
Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Ucchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: iezzi a. Circulation. 2001 Aug 21;104(8):921-7. doi: 10.1161/hc3401.093152. Circulation. 2001. PMID: 11514380
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Mascellanti M, Fazia M, Iezzi A, Cuccurullo C, Pini B, Bucci M, Santucci A, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: iezzi a. Circulation. 2003 Dec 2;108(22):2776-82. doi: 10.1161/01.CIR.0000103700.05109.0D. Epub 2003 Nov 17. Circulation. 2003. PMID: 14623801 Clinical Trial.
98 results